ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARC MITCHELL M.D.

Internal Medicine

8,883

$557K

575
544 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $56

BRADLEY HARRIS M.D.

Internal Medicine

8,784

$542K

669
593 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

RANDALL REIMER MD

Internal Medicine

8,654

$440K

511
433 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

MARC CORDOVA M.D.

Internal Medicine

8,623

$545K

599
555 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $56

JEFFREY HOOPER D.O.

Internal Medicine

8,613

$409K

367
289 are 65+

20%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

GREGORY HALLAS M.D.

Internal Medicine

8,610

$402K

426
381 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

RICO ROMANO MD

Internal Medicine

8,577

$416K

564
445 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

PAULA RENZI DO

Internal Medicine

8,561

$391K

335
205 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

BRIAN SEPPI MD

Internal Medicine

8,478

$443K

380
337 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

DON ANDREWS MD

Internal Medicine

8,442

$399K

558
469 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

MICHAEL HIXON M.D.

Internal Medicine

8,343

$380K

532
445 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

JON GARDNER MD

Internal Medicine

8,326

$403K

378
323 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

PETR SLAPNICKA MD

Internal Medicine

8,321

$383K

425
374 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

JOLANTA OLSON M.D.

Internal Medicine

8,305

$353K

409
335 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $56

BRIAN MCDONALD MD

Internal Medicine

8,294

$490K

523
456 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

STEPHEN JOHNSON MD

Internal Medicine

8,284

$458K

442
399 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

ALBERT FABIANO MD

Internal Medicine

8,272

$402K

317
256 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

RYAN ROMMEL GUANZON MD

Internal Medicine

8,254

$453K

549
419 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

ANKIT PATEL M.D.

Internal Medicine

8,250

$403K

304
225 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

EILEEN OLINGER MD

Internal Medicine

8,238

$460K

424
381 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

DAVID DOORNINK MD

Internal Medicine

8,202

$392K

588
549 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

JOHN HAMILL MD

Internal Medicine

8,193

$617K

300
202 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $56

WARD CHOW MD

Internal Medicine

8,189

$399K

446
404 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

MANUEL KARLIN MD

Internal Medicine

8,155

$356K

438
381 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

JAMES CAMPBELL M.D.

Internal Medicine

8,153

$451K

355
324 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank